Tried-and-True, Allow Me to Introduce You to Wired and New
With a technology like VR, we can readily tap into multiple learning styles by integrating different types of media into a single experience.
Featured Posts
Pharma Innovators Special Feature 2018: Focus on innovation
In seeking innovative players that could change pharma and healthcare, Med Ad News found the developer of an app that helps people determine what illnesses are in their neighborhoods; the creator of a wearable injector that allows patients on biologics to receive these drugs outside the clinic; and a designer of a deep learning network aimed at giving pharma and healthcare companies a handle on their data.
Special Feature: Mobile in the hospital
As private practices close and the number of doctors joining rep-restricted hospital-based and integrated delivery networks of healthcare increases, pharma needs to look at the advantages of mobile marketing to “detail” these hospital-based professionals.
Is the ADHD Market Ready for a Disruptor? An Interview with Highland Therapeutics’ David Lickrish
David Lickrish – president, founder and chief executive officer of Highland Therapeutics and Ironshore Therapeutics – spoke with BioSpace about the companies’ Jornay PM (methylphenidate HCL Extended-Release CLL Capsules) and how the new drug fits into the overall ADHD therapeutic market.
Yes, counting steps might make you healthier
People who track their daily steps may not only be more active, they may also be less likely to develop health problems that lead to events like heart attacks or broken bones, a new study suggests.
New Klick Health Research: Google Assistant Recognizes Medication Names Better Than Alexa and Siri
Klick Health research found Google Assistant’s comprehension of the most commonly dispensed medication names in the U.S. was, on average, almost twice as accurate as Alexa and Siri’s.
Experimental mobile app helps manage migraines
A smartphone-based relaxation app could help migraine sufferers reduce the number of headaches they get each month, a small study suggests.
Vertex Pharmaceuticals expands into Duchenne gene therapy with new deals
Vertex Pharmaceuticals will acquire privately held Exonics Therapeutics for an upfront payment of $245 million and potential milestone payments of up to $750 million.
Pitango Venture Capital launches $150 million health technology fund
Israel’s Pitango Venture Capital is launching a fund that will reach $150 million to invest in health technology.
From Isolation to Anticipation: How technology continues to improve the lives of rare disease families
Working in the rare disease space has never been more rewarding than it is today. Technology is turning what was once thought to be impossible into actual, tangible realities for physicians, patients, and families. There are many exciting advancements happening now – in real time – and even more on the horizon that demand our attention and advocacy to help bring them to light.
The ABCDs of a rare disease launch
The first rule of rare: There are no rules. There are over 7,000 different rare diseases – each with its own symptomology, history, and clinical and political landscape. Most are virgin territory for marketers; only 5 percent have an approved treatment.
Innovation Week at FCB Health focuses on tech advances in healthcare advertising
FCB Health Network held its annual Innovation Week from May 7-9, 2019. Here’s a topline summary for anyone who missed the event.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com. 
June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!